Advances in Pharmacogenetics and Pharmacogenomics
- 1 September 2000
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 40 (9) , 930-938
- https://doi.org/10.1177/00912700022009666
Abstract
Large differences among normal human subjects in the efficacy and safety of many therapeutic agents are caused by genetically controlled polymorphisms of drug‐metabolizing enzymes, drug transporters,...Keywords
This publication has 45 references indexed in Scilit:
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Influence of the Genotype on the Clinical Course of the Long-QT SyndromeNew England Journal of Medicine, 1998
- Influence of the Angiotensin II Type 1 Receptor Gene Polymorphism on the Effects of Perindopril and Nitrendipine on Arterial Stiffness in Hypertensive IndividualsHypertension, 1996
- Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor geneThe Lancet, 1996
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Genetic control of dicumarol levels in manJournal of Clinical Investigation, 1968
- Genetic Control of Drug Levels in Man: PhenylbutazoneScience, 1968